The AIDS and Cancer Virus Program investigates ways to diagnose, prevent, and treat HIV infection and AIDS-related tumors associated with cancer viruses, such as Kaposi sarcoma–associated herpesvirus. We have principal investigator-headed research sections and research support cores that provide innovative, often unique, capabilities in support of our program, as well as the National Institutes of Health and extramural investigators. 

Research Sections and Support Core Capabilities

Furthering the field through support and collaboration

Our program's culture includes widely sharing our innovations and capabiliites, including novel experimental models, reagents, and analytical methods through a variety of collaborative mechanisms, including selected laboratory services or analytical capabilties available through the Technical Services Agreement program

Collaboration Opportunities

AIDS and Cancer Virus research sections and research support cores collaborate with scientists within and outside the National Institutes of Health to address key remaining challenges in the prevention and treatment of HIV infection and associated conditions. We engage with external investigators through partnership mechanisms including Cooperative Research and Development Agreement (CRADA), Material Transfer Agreement (MTA), Technical Service Agreement (TSA).

Contact Dr. Jeffrey Lifson or the specific section or core leader. 

Graphic of barcoded DNA
Novel AIDS virus genetic tagging model

Technology innovation enhances study of virus:host interactions

Molecular barcoding of AIDS viruses allows researchers to track chains of infection initiated by individual virus variants, enabling sensitive, high-level resolution of virus:host interactions in NHP models in unprecedented detail.
Additional Content

Open Positions in AIDS & Cancer Virus Program